From being late adopters of disruptive technologies, the pharmaceutical and life sciences industry has come to a phase where in they are at the luxury to choose from a plethora of solution providers, with multiple innovations at their disposal. Driving factors for this exponential increase in innovation include a rise in the R&D activities by various pharma and biopharma companies, growing application of software solutions in medical trials, and rising government funding for promoting clinical research programs. And in increasingly digital environments, successful trials require collaboration, digital knowledge and patient engagement. As such, the CTMS market is projected to grow at a CAGR of 11.5 percent in the next four years.
March - April 2017| View Digital Version
Silji Abraham, CIO, MilliporeSigma
Benson Hsu, Vice President, Data and Analytics, Sanford Health
Marc Probst, CIO and VP, Intermountain Healthcare
Eric Perakslis, Sr. VP, Informatics, Takeda Pharmaceutical Company Limited
Pracha Eamranond, Senior VP, Medical Affairs and Population and Meghan O’Neill, Project Manager in Information Systems, Lawrence General Hospital
Michelle Woodley, Chief Nursing Information Officer, St. Joseph Health
Paul Shawah, VP, Commercial Cloud Strategy, Veeva Systems and President at Align Bio-pharma
Scott Lust, Senior Consultant in Clinical Operations at Fuse by Cardinal Health and Brent Stutz, SVP of Commercial Technologies at Cardinal Health
Charlton Park, Chief Analytics Officer at University of Utah Hospitals and Clinics
Bob Oliver, President and CEO, Otsuka America Pharmaceutical, Inc.
The pharmaceutical sector is taking giant leaps into the future by implementing new strategies to
The ability to process large amounts of data from different sources and extract the relevant
The biotech industry has experienced a rapid expansion of data in the recent years. Biotech
New architectures of databases and new IT infrastructures enable the biotech companies to overcome
The Clinical Data Management (CDM) process, like any clinical trial, begins with the end in mind.
Pharmaceutical companies are traditionally known for their commercial models–an army of sales reps